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In an observational study published in the previous issue 
of Critical Care, Elseviers and colleagues [1] report that 
the mortality of critically ill patients treated with renal 
replacement therapy (RRT) for acute kidney injury (AKI) 
is much higher than that of those treated by a 
conservative strategy (that is, without RRT). RRT remains 
an independent factor associated with a higher mortality 
after adjustments for acute disease severity (risk ratio 
[RR] 1.73, 95% conﬁ  dence interval [CI] 1.4 to 2.2) based 
on the Stuivenberg Hospital Acute Renal Failure (SHARF) 
score as well as other corrections for usually well-
established prognostic factors (age, sex, Sequential Organ 
Failure Assessment [SOFA] score, type of AKI, delayed 
admission, and clinical conditions). Th  is observation 
might have two alternative explanations: ﬁ  rst, RRT per se 
could worsen the prognosis of acutely ill patients 
experiencing AKI; second, AKI of patients treated by 
RRT was more severe and this greater severity is not fully 
reﬂ  ected by the severity scores and adjustment factors 
used in the multivariable models of the study. In fact, the 
role of AKI, as an independent factor for mortality, is 
currently well documented, regardless of the severity of 
AKI [2,3]. Th  e subpopulation requiring RRT in the 
intensive care unit represents the more severe population, 
and the need for RRT appears to be an independent risk 
factor for death [4]. However, the need for renal 
supportive care is nonetheless a marker of severity. Th  e 
speciﬁ  c role of RRT was ﬁ  rst proposed by Guerin and 
colleagues [5] in their French epidemiological study. 
Indeed, they reported, in a multi  ple logistic regression 
analysis, that the absence of hemo  dialysis in their severe 
AKI population (serum creatinine [sCr] of greater than 
300 μmol/L, urine output of less than 500 mL/24 hours, 
or the need for hemo  dialysis) was a signiﬁ  cant predictor 
of survival (odds ratio 1.78, 95% CI 1.05 to 3.04; P 0.032). 
Th  is ﬁ   nding is of paramount importance given the 
current trend to initiate RRT early in the course of AKI. 
Moreover, recent epidemiological [6] or prospective 
controlled [7] studies show that the main criteria for RRT 
initiation are based on low urine output prior to a marked 
increase in sCr or serum urea level. RRT remains 
associated with a high mortality, and given the lack of 
survival improvement using continuous RRT [8] or 
augmented delivered dose [7,9], early initia  tion of RRT 
might be promising. Actually, numerous retrospective 
studies report a better outcome with earlier initiation, 
but conﬂ  icting results are reported by other studies [10]. 
Finally, a recent meta-analysis [11] shows a barely 
signiﬁ  cant decrease in mor  tality using early initiation of 
RRT in prospective studies (RR 0.64, 95% CI 0.40 to 1.05; 
P <0.08) and a signiﬁ   cant decrease in mortality using 
early initiation of RRT in observational studies (RR 0.72, 
95% CI 0.64 to 0.82; P <0.001). Th   is new strategy seems 
attractive, but regarding the lack of strong data in favor of 
any beneﬁ  cial eﬀ  ect, we should pay heed to the potential 
adverse eﬀ  ects. Unfortunately, the study by Elseviers and 
colleagues [1] presents many shortcomings, which 
hamper any deﬁ  nitive conclusion. First, the study is an 
observational trial and no pre  speciﬁ  ed criteria regarding 
RRT indications and the timing of initiation were 
provided in the diﬀ  erent centers. Th   is shortcoming may 
explain the heterogeneity in the rate of patients treated 
with RRT between the diﬀ   erent centers and the 
associated mortality. Second, adjustment criteria did not 
take into account speciﬁ   c AKI characteristics, like 
oliguria, or speciﬁ  c prognostic scores based on metabolic 
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colleagues report that renal replacement therapy (RRT) 
in acutely ill patients treated for acute kidney injury is 
an independent risk factor for death. This result may 
question the benefi  t of the current practice of early RRT 
initiation.
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© 2011 BioMed Central Ltddistur  bances (that is, RIFLE [Risk, Injury, Failure, Loss, 
and End-stage kidney disease] or AKIN [Acute Kidney 
Injury Network]). We can guess that intensivists were 
prompt to initiate RRT in patients with oliguria or severe 
metabolic abnormalities and thereby to select a more 
severe population. Th   e higher mortality could be linked 
to the AKI severity itself rather than to a speciﬁ  c eﬀ  ect of 
RRT. Th  e real problem in clinical practice is the early 
detection of AKI patients for whom RRT will be 
mandatory. In this population, we could probably start 
RRT early, whereas in the others, we could delay the 
initiation. As we wait for a large prospective study to test 
the beneﬁ  t of early initiation of RRT, it seems reasonable, 
in the absence of a current clinical or biological marker of 
RRT requirement, to keep in mind that widespread use of 
early initiation may lead to an excess risk of complications 
and perhaps to a higher mortality than expected.
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